Binance.US expansion fuels a $5.24 Injective rally

Traders Union
All News
Crypto News
Injective gains 7.36% today to $5.24

Highlights

Injective's listing on Binance.US expands its accessibility and may enhance liquidity and demand among U.S. investors.
Ecosystem growth and active development continue to support sustained momentum for Injective alongside the new exchange debut.
INJ demonstrates a bullish technical profile with strong momentum signals, but forecasts suggest consolidation between $5.10 and $5.75 is likely next week.

U.S. listing on Binance.US drives liquidity and investor access

Investor access to Injective has expanded with the token becoming newly available on Binance.US, directly increasing its visibility and tradability among U.S. participants. This development provides a clearer path for new and existing American investors to engage with the asset, translating to higher market demand and improved liquidity. The news coincides with continued growth in the Injective ecosystem, supporting sustained development activity and helping underpin current market momentum.

Bullish momentum strengthens with buy signals amid mixed indicators

INJ is trading above the MA-20 at $4.32, MA-50 at $3.62, and MA-200 at $4.34, with the Ichimoku Kijun located at $4.72 acting as immediate chart support. Momentum indicators, including MACD and ADX on the daily timeframe, register active Buy signals. The RSI at 64.39 and CCI at 95.11 are positioned in upper-neutral territory, supportive of further upside but not displaying classic overbought signals. Stoch RSI is oversold, creating a divergence from other momentum readings, while BBP at 0.79 indicates strong buyer dominance intraday. The Awesome Oscillator remains neutral, providing a minor counterbalance to the bullish momentum profile.

Limited upside as consolidation expected within defined trading band

Looking to the next week, typical volatility suggests a price corridor between $5.10 and $5.75, reflecting a volatility band close to current levels. The probability of further price gains appears low (less than 20%), favoring consolidation over a sustained move higher. In the bullish scenario, a close above $5.75 could trigger renewed upside, though this would encounter increasing resistance from higher timeframe trends. A break below $5.10 would indicate a sentiment reversal and open the path for a deeper retracement toward prior support zones.

Anton Kharitonov, expert at Traders Union, sees cautious optimism for Injective after the token’s listing on Binance.US broadened its U.S. market exposure and liquidity. He notes that technical momentum remains positive, but signals for sustained upside are not decisive. Consolidation is more likely unless there is a clear breakout above $5.75. "Until we see a convincing move beyond resistance, my view remains defensive with a focus on risk controls," Kharitonov concludes.

Earlier, analysts noted that Injective was demonstrating emerging bullish momentum amid ongoing supply reductions and expanding ecosystem activity, though overall conditions favored price consolidation rather than a sustained rally. The most recent developments—namely expanded U.S. market access and continued technical strength—strengthen this thesis, making a close above $5.75 a pivotal level to monitor for any potential shift toward renewed upside.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.